Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hepatitis B Antibody Persistence and Challenge in Children
NCT01333813Phase 4Completed
- Sponsor
- GSK
- Start
- Apr 2011
- Primary completion
- Sep 2011
- Modality
- Split/Subunit Vaccines, Recombinant Protein Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of hepatitis b vaccine recombinant in hepatitis B (HBV), sponsored by GSK. Started Apr 2011; status: completed.
02
Drugs
hepatitis b vaccine recombinant
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT01333813.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01333813.